Form D · Venture Capital Fund
Genesis BioCapital Fund I, LP
Chattanooga, TN · CIK 0002053141
Offering snapshot reported Jan 23, 2026 · SEC filing
- Reported sold
- $18.5M Indefinite offering
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 23, 2026 | Amendment | $18,480,000 | No comparison | Not reported | SEC filing |
| Jan 23, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-536080
Source: Form D, filed Jan 23, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Genesis Bio Capital Fund I Gp, Lp | Executive |
| Genesis Bio Capital Management, Llc | Executive |
| Ray Tabibiazar | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
200 West Mlk Blvd. Suite 1000, Pmb #3073
Chattanooga, TN, 37402
Chattanooga, TN, 37402